Quality of factor XI activity testing in North American specialized coagulation laboratories

N. D. Zantek, P. Hsu, P. Meijer, K. J. Smock, E. A. Plumhoff, M. A. Refaai, E. M. Van Cott

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction: The performance of factor XI activity (FXI) by laboratories in the North American Specialized Coagulation Laboratory Association proficiency testing program was analyzed. Methods: Over 10 years (2003-2013), 80 samples were distributed; 33-55 laboratories participated per exercise providing 3833 total responses. Analysis was performed on numeric results and qualitative classification of results. Results: The sample FXI levels ranged from 3.8 to 154.0 IU/dL. The overall interlaboratory average coefficient of variation (CV%) was 17.5%; the CV was higher for a sample with low (3.8 IU/dL) FXI. Results were correctly classified as abnormal (100%) for a sample with 3.8 IU/dL FXI and normal/borderline normal (97.7%) for 45 samples with 80 to < 140 IU/dL FXI. The classification was heterogeneous for samples with FXI of 50 to < 80 IU/dL. Six specimens were repeat-tested from 2007 to 2013. The mean FXI was not significantly different in laboratories using the same method on both exercises, suggesting good intralaboratory precision over time. Univariate analysis of data from 2011 to 2012 did not find a consistent significant difference among the activators, analyzers, calibrators, and FXI-deficient plasmas. Conclusion: Laboratories generally performed well in assessment of FXI based on interlaboratory precision when FXI >30 IU/dL and on classification of samples with very low or normal FXI.

Original languageEnglish (US)
Pages (from-to)99-107
Number of pages9
JournalInternational Journal of Laboratory Hematology
Volume37
Issue numberS1
DOIs
StatePublished - May 1 2015

Fingerprint

Factor XI
Coagulation
Testing
Laboratory Proficiency Testing

Keywords

  • Factor XI
  • Intrinsic pathway
  • North American specialized laboratory association
  • Proficiency testing
  • Quality

Cite this

Quality of factor XI activity testing in North American specialized coagulation laboratories. / Zantek, N. D.; Hsu, P.; Meijer, P.; Smock, K. J.; Plumhoff, E. A.; Refaai, M. A.; Van Cott, E. M.

In: International Journal of Laboratory Hematology, Vol. 37, No. S1, 01.05.2015, p. 99-107.

Research output: Contribution to journalArticle

Zantek, N. D. ; Hsu, P. ; Meijer, P. ; Smock, K. J. ; Plumhoff, E. A. ; Refaai, M. A. ; Van Cott, E. M. / Quality of factor XI activity testing in North American specialized coagulation laboratories. In: International Journal of Laboratory Hematology. 2015 ; Vol. 37, No. S1. pp. 99-107.
@article{a6e1a9c7bddb40739ca403a92bb39eb7,
title = "Quality of factor XI activity testing in North American specialized coagulation laboratories",
abstract = "Introduction: The performance of factor XI activity (FXI) by laboratories in the North American Specialized Coagulation Laboratory Association proficiency testing program was analyzed. Methods: Over 10 years (2003-2013), 80 samples were distributed; 33-55 laboratories participated per exercise providing 3833 total responses. Analysis was performed on numeric results and qualitative classification of results. Results: The sample FXI levels ranged from 3.8 to 154.0 IU/dL. The overall interlaboratory average coefficient of variation (CV{\%}) was 17.5{\%}; the CV was higher for a sample with low (3.8 IU/dL) FXI. Results were correctly classified as abnormal (100{\%}) for a sample with 3.8 IU/dL FXI and normal/borderline normal (97.7{\%}) for 45 samples with 80 to < 140 IU/dL FXI. The classification was heterogeneous for samples with FXI of 50 to < 80 IU/dL. Six specimens were repeat-tested from 2007 to 2013. The mean FXI was not significantly different in laboratories using the same method on both exercises, suggesting good intralaboratory precision over time. Univariate analysis of data from 2011 to 2012 did not find a consistent significant difference among the activators, analyzers, calibrators, and FXI-deficient plasmas. Conclusion: Laboratories generally performed well in assessment of FXI based on interlaboratory precision when FXI >30 IU/dL and on classification of samples with very low or normal FXI.",
keywords = "Factor XI, Intrinsic pathway, North American specialized laboratory association, Proficiency testing, Quality",
author = "Zantek, {N. D.} and P. Hsu and P. Meijer and Smock, {K. J.} and Plumhoff, {E. A.} and Refaai, {M. A.} and {Van Cott}, {E. M.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1111/ijlh.12359",
language = "English (US)",
volume = "37",
pages = "99--107",
journal = "International Journal of Laboratory Hematology",
issn = "1751-5521",
publisher = "Wiley-Blackwell",
number = "S1",

}

TY - JOUR

T1 - Quality of factor XI activity testing in North American specialized coagulation laboratories

AU - Zantek, N. D.

AU - Hsu, P.

AU - Meijer, P.

AU - Smock, K. J.

AU - Plumhoff, E. A.

AU - Refaai, M. A.

AU - Van Cott, E. M.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Introduction: The performance of factor XI activity (FXI) by laboratories in the North American Specialized Coagulation Laboratory Association proficiency testing program was analyzed. Methods: Over 10 years (2003-2013), 80 samples were distributed; 33-55 laboratories participated per exercise providing 3833 total responses. Analysis was performed on numeric results and qualitative classification of results. Results: The sample FXI levels ranged from 3.8 to 154.0 IU/dL. The overall interlaboratory average coefficient of variation (CV%) was 17.5%; the CV was higher for a sample with low (3.8 IU/dL) FXI. Results were correctly classified as abnormal (100%) for a sample with 3.8 IU/dL FXI and normal/borderline normal (97.7%) for 45 samples with 80 to < 140 IU/dL FXI. The classification was heterogeneous for samples with FXI of 50 to < 80 IU/dL. Six specimens were repeat-tested from 2007 to 2013. The mean FXI was not significantly different in laboratories using the same method on both exercises, suggesting good intralaboratory precision over time. Univariate analysis of data from 2011 to 2012 did not find a consistent significant difference among the activators, analyzers, calibrators, and FXI-deficient plasmas. Conclusion: Laboratories generally performed well in assessment of FXI based on interlaboratory precision when FXI >30 IU/dL and on classification of samples with very low or normal FXI.

AB - Introduction: The performance of factor XI activity (FXI) by laboratories in the North American Specialized Coagulation Laboratory Association proficiency testing program was analyzed. Methods: Over 10 years (2003-2013), 80 samples were distributed; 33-55 laboratories participated per exercise providing 3833 total responses. Analysis was performed on numeric results and qualitative classification of results. Results: The sample FXI levels ranged from 3.8 to 154.0 IU/dL. The overall interlaboratory average coefficient of variation (CV%) was 17.5%; the CV was higher for a sample with low (3.8 IU/dL) FXI. Results were correctly classified as abnormal (100%) for a sample with 3.8 IU/dL FXI and normal/borderline normal (97.7%) for 45 samples with 80 to < 140 IU/dL FXI. The classification was heterogeneous for samples with FXI of 50 to < 80 IU/dL. Six specimens were repeat-tested from 2007 to 2013. The mean FXI was not significantly different in laboratories using the same method on both exercises, suggesting good intralaboratory precision over time. Univariate analysis of data from 2011 to 2012 did not find a consistent significant difference among the activators, analyzers, calibrators, and FXI-deficient plasmas. Conclusion: Laboratories generally performed well in assessment of FXI based on interlaboratory precision when FXI >30 IU/dL and on classification of samples with very low or normal FXI.

KW - Factor XI

KW - Intrinsic pathway

KW - North American specialized laboratory association

KW - Proficiency testing

KW - Quality

UR - http://www.scopus.com/inward/record.url?scp=84929378482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929378482&partnerID=8YFLogxK

U2 - 10.1111/ijlh.12359

DO - 10.1111/ijlh.12359

M3 - Article

VL - 37

SP - 99

EP - 107

JO - International Journal of Laboratory Hematology

JF - International Journal of Laboratory Hematology

SN - 1751-5521

IS - S1

ER -